You are here: Industry Insights > COVID-19 vaccine

News List

Russia authorises use of single-dose Covid-19 vaccine Sputnik Light pharmaceutical-technology
May 08, 2021
Sputnik Light, which is based on the human adenoviral vector platform, is the first component, a recombinant human adenovirus serotype number 26 (rAd26), of the Sputnik V Covid-19 vaccine.
Novavax Covid-19 vaccine provides cross-protection against B.1.351 variant pharmaceutical-technology
May 07, 2021
The protein-based vaccine candidate NVX-CoV2373 is made from the genetic sequence of the first SARS-CoV-2 strain. It is adjuvanted with the company’s saponin-based Matrix-M to boost immune response and neutralising antibodies.
Health Canada approves Pfizer and BioNTech’s Covid-19 vaccine for adolescents pharmaceutical-technology
May 07, 2021
With Health Canada authorisation, the Pfizer and BioNTech vaccine became the first-of-its-kind indicated for this age group to receive approval in the country.
Pfizer in talks with India over expedited approval for COVID-19 vaccine expresspharma
May 07, 2021
Albert Bourla, CEO, Pfizer also announced a donation of medicines worth more than $70 million.
Safety issues over mass production of COVID vaccines: A techno-legal perspective expresspharma
May 07, 2021
It has been more than a year-long struggle now with restrictions, efforts, recovery and fight by nations around the world against the virus but the pandemic is showing no signs of abating.
Reliable cold storage solutions to safeguard COVID vaccines storage and distribution expresspharma
May 07, 2021
The COVID-19 vaccines have proven to be a breakthrough in the fight against the pandemic. The demand for vaccine storage solutions is increasing in parallel with the massive R&D and manufacturing effort to accelerate the vaccine development.
MoHF&W issues guidelines for COVID-19 vaccine import by private sector expresspharma
May 07, 2021
MoHF&W has said that the ready-to-use imported COVID vaccine would be allowed to be utilised entirely in the other-than- Government of India channel.”
$150 million made available for COVID-19 vaccine adverse event compensation scheme europeanpharmaceuticalreview
May 06, 2021
The COVAX No-fault Compensation Program will offer individuals in 92 lower-income countries and economies compensation for serious adverse events associated with COVID-19 vaccines distributed through COVAX.
UK buys another 60 million doses of Pfizer/BioNTech vaccine pharmatimes
May 06, 2021
The UK government has secured an extra 60 million doses of Pfizer/BioNTech’s COVID-19 vaccine, in a bid to strengthen plans for the autumn COVID-19 vaccination programme.
Meissner Announces Award of $13.4 Million Contract from BARDA americanpharmaceuticalreview
May 06, 2021
Meissner Filtration Products has been awarded a $13.4 million contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the office of the Assistant Secretary for Preparedness and Response at the ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page